GO:0006694 steroid biosynthetic process: Steroidogenesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006694 steroid biosynthetic process describes the chemical reactions and pathways that form steroids, compounds built on a 1,2-cyclopentanoperhydrophenanthrene nucleus, including both de novo synthesis and interconversion.
• The pathway is best known for adrenal, gonadal and placental steroidogenesis, but steroid biosynthetic capacity is also relevant in brain, skin, adipose and immune contexts.
• Serum and urine steroid metabolomes reflect the integrated output of steroid biosynthesis, metabolism and excretion, making them powerful readouts for endocrine research.
• Defects in steroidogenesis cause disorders such as congenital adrenal hyperplasia and other endocrine syndromes, and steroid biomarkers are central to adrenal disease diagnosis.
• Steroid conjugates such as sulfates and disulfates are increasingly recognized as physiologically important products and reservoirs within steroid pathways.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of steroidogenic genes, while library screening and bioinformatics can map pathway dependencies.
Description
GO:0006694 steroid biosynthetic process is the Gene Ontology biological process that covers the chemical reactions and pathways resulting in the formation of steroids, defined by the presence of a 1,2-cyclopentanoperhydrophenanthrene nucleus, and includes both de novo formation and steroid interconversion by modification. In practice, this term captures the enzymatic steps that convert cholesterol or related sterol precursors into bioactive steroid hormones and intermediates, as well as the interconversions that diversify the steroid pool. Because steroids act as hormones, signaling molecules and metabolic regulators, the pathway sits at the center of endocrine physiology and is a frequent focus of disease research. For researchers, GO:0006694 is not a single linear route but a network of tissue-specific branches. The adrenal cortex, gonads, placenta and, in some contexts, brain and peripheral tissues express distinct combinations of steroidogenic enzymes, so the same GO term can describe different chemical outputs depending on the cellular context. This is why steroid metabolomics has become a key approach: serum and urine steroid profiles integrate the activity of multiple biosynthetic and metabolic steps and can reveal pathway shifts that are not obvious from single-hormone assays. Studying steroid biosynthetic process therefore requires both molecular tools and systems-level readouts. Genetic models that remove, mutate or overexpress individual steroidogenic enzymes can establish causality, while profiling methods such as steroid metabolomics, transcriptomics and proteomics place those enzymes in a pathway context. The sections below summarize the definition, mechanism, key genes, disease links and experimental strategies for GO:0006694.
steroid biosynthetic process At A Glance
| GO ID | GO:0006694 |
|---|---|
| GO term | steroid biosynthetic process |
| Ontology | biological_process |
| Synonym | steroid anabolism; steroid biosynthesis; steroid formation; steroidogenesis; steroid synthesis |
| Major function | Formation and interconversion of steroids, including steroid hormones and intermediates, via enzymatic reactions |
| Definition source | QuickGO definition: chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2-cyclopentanoperhydrophenanthrene nucleus; includes de novo formation and steroid interconversion by modification |
| Representative tissues | Adrenal cortex, gonads, placenta and other steroidogenic tissues |
| Key readouts | Serum and urine steroid metabolomes, steroid biomarkers and enzyme expression profiles |
| Disease relevance | Disorders of steroidogenesis, adrenal disease and endocrine-related conditions |
What Is GO:0006694?
In this article, GO:0006694 steroid biosynthetic process is understood as the set of biochemical reactions and pathways that produce steroids, molecules characterized by a 1,2-cyclopentanoperhydrophenanthrene nucleus. The term explicitly includes de novo steroid formation as well as steroid interconversion by modification, meaning it covers both the construction of the steroid skeleton and the enzymatic remodeling of existing steroids into other steroid products.
Why Is steroid biosynthetic process Important in Cell Biology?
GO:0006694 steroid biosynthetic process matters because steroids are among the most potent and widely acting signaling molecules in human physiology, and their production must be tightly controlled. The pathway supplies glucocorticoids, mineralocorticoids, androgens, estrogens and progestins, and its intermediates can also have biological activity. Because steroid biosynthesis is distributed across several tissues and is subject to multi-enzyme regulation, defects at different steps produce distinct clinical phenotypes, which makes the pathway a rich source of disease mechanisms and therapeutic targets. In addition, steroid bioconversions are exploited industrially and pharmacologically, underscoring the broader importance of understanding these reactions.
• Provides the biosynthetic route to glucocorticoids, mineralocorticoids, androgens, estrogens and progestins.
• Underlies endocrine disorders caused by defects in steroidogenic enzymes.
• Enables steroid biomarker discovery and interpretation in adrenal disease.
• Connects to steroid metabolism and excretion through serum and urine steroid metabolomes.
• Includes interconversion reactions that generate diverse bioactive steroids.
• Involves steroid conjugation and sulfation, expanding the functional steroid pool.
• Is relevant to microbial and industrial steroid bioconversions.
• Supports research on tissue-specific steroidogenesis beyond classic endocrine organs.
• Offers multiple enzymatic nodes for pharmacological and genetic intervention.
• Requires integrated multi-omics and metabolomic approaches for accurate study.
What Happens During steroid biosynthetic process?
Precursor supply and entry into the pathway
In simple terms: The pathway needs a starting material, usually cholesterol, before it can build steroid products.
Steroid biosynthetic process begins with the availability of sterol precursors, most commonly cholesterol, which is delivered to steroidogenic cells and used as the substrate for the first committed enzymatic steps. The pathway is therefore dependent on precursor supply and on the expression of enzymes that can act on sterols. Because the QuickGO definition includes de novo formation and interconversion, the entry point can also be an existing steroid that is subsequently modified.
De novo steroid formation
In simple terms: Cells chemically transform cholesterol step by step into steroid hormones.
De novo steroid formation involves a series of enzymatic reactions that convert cholesterol into pregnenolone and then into downstream steroids. These reactions are catalyzed by cytochrome P450 enzymes and hydroxysteroid dehydrogenases, and the exact route depends on the tissue-specific enzyme repertoire. The resulting products include glucocorticoids, mineralocorticoids, androgens, estrogens and progestins, which are released or further metabolized.
Steroid interconversion by modification
In simple terms: Existing steroids can be chemically remodeled into other steroids.
The GO term explicitly includes steroid interconversion by modification, meaning that steroids can be converted from one form to another through oxidation, reduction, hydroxylation or related reactions. This step diversifies the steroid pool and can activate or inactivate hormones. Interconversion is central to the dynamic balance of active and inactive steroids in circulation and tissues.
Conjugation and downstream handling
In simple terms: Steroids can be tagged with chemical groups that change how they behave in the body.
Steroid biosynthetic process intersects with conjugation reactions such as sulfation, which produce steroid sulfates and disulfates. These conjugates can serve as storage forms or bioactive molecules and are part of the broader steroid landscape measured in metabolomic studies. Serum and urine steroid metabolomes capture the combined output of biosynthesis, interconversion, conjugation and excretion.
Tissue-specific pathway branches
In simple terms: Different tissues make different steroids because they express different enzymes.
The adrenal cortex, gonads and placenta are classic steroidogenic tissues, but other tissues can also express steroidogenic enzymes. This tissue-specific expression creates distinct pathway branches and outputs. As a result, the same GO term can describe different chemical end products depending on the cellular context, which is a key consideration in experimental design.
Key Genes Involved in GO:0006694 steroid biosynthetic process
The genes below represent widely studied components and regulators associated with steroid biosynthetic process and its research applications.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STAR | Transfers cholesterol into mitochondria for steroidogenesis | Rate-limiting step in steroid hormone synthesis |
| CYP11A1 | Converts cholesterol to pregnenolone | First committed step of steroid biosynthesis |
| HSD3B2 | Catalyzes 3beta-hydroxysteroid dehydrogenase activity | Key node in adrenal and gonadal steroidogenesis |
| CYP21A2 | 21-hydroxylase in glucocorticoid and mineralocorticoid synthesis | Classic defect in congenital adrenal hyperplasia |
| CYP11B1 | 11beta-hydroxylase for cortisol synthesis | Adrenal steroidogenesis and disease biomarker studies |
| CYP11B2 | Aldosterone synthase for mineralocorticoid synthesis | Adrenal disease and hypertension research |
| CYP17A1 | 17alpha-hydroxylase/17,20-lyase | Androgen and glucocorticoid pathway branch point |
| CYP19A1 | Aromatase converting androgens to estrogens | Estrogen biosynthesis research |
| SRD5A1 | 5alpha-reductase for androgen interconversion | Androgen metabolism studies |
| SRD5A2 | 5alpha-reductase for androgen activation | Androgen biology and disease models |
| AKR1C3 | Hydroxysteroid dehydrogenase activity | Steroid interconversion and cancer research |
| HSD17B1 | 17beta-hydroxysteroid dehydrogenase | Estrogen and androgen biosynthesis |
| HSD17B2 | 17beta-hydroxysteroid dehydrogenase | Steroid inactivation and balance |
| SULT2A1 | Steroid sulfotransferase | Steroid sulfate formation |
| STS | Steroid sulfatase | Steroid conjugate metabolism |
| NR5A1 | Steroidogenic factor 1 transcription factor | Regulates steroidogenic gene expression |
| POR | Cytochrome P450 oxidoreductase | Supports multiple steroidogenic P450 enzymes |
How Is steroid biosynthetic process Regulated?
Steroid biosynthetic process is regulated at multiple levels, including transcription of steroidogenic enzymes, substrate availability and post-translational control of enzyme activity. Tissue-specific transcription factors such as NR5A1 help set the steroidogenic program, while the delivery of cholesterol to mitochondria controls the rate of de novo synthesis. Because serum and urine steroid metabolomes reflect the integrated activity of biosynthesis, interconversion and excretion, changes in regulation can be detected as shifts in steroid profiles. Steroid conjugation and sulfation add another regulatory layer by modifying steroid availability and activity.
steroid biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP21A2 | Congenital adrenal hyperplasia and impaired glucocorticoid synthesis | Point-mutation knock-in to model specific enzyme defects |
| CYP11B1 | Adrenal steroidogenesis disorders and cortisol imbalance | Knockout in adrenal cell models |
| CYP11B2 | Mineralocorticoid excess and adrenal disease | Overexpression and knockout models |
| SULT2A1 | Steroid sulfate metabolism and endocrine balance | Knockout and overexpression in steroidogenic cells |
| STS | Steroid conjugate processing and related disorders | Knockout models with steroid metabolomics readouts |
Disorders of steroidogenesis
Defects in steroid biosynthetic process cause a range of endocrine disorders, often with distinct clinical presentations depending on the affected enzymatic step. Congenital adrenal hyperplasia is a classic example, and other defects of steroidogenesis can affect glucocorticoid, mineralocorticoid or sex steroid production. Genetic and biochemical studies of these defects have clarified the roles of individual steroidogenic enzymes in human physiology.
Adrenal disease and steroid biomarkers
Steroid biomarkers are widely used in the evaluation of adrenal disease. Because steroid biosynthetic process generates measurable intermediates and products, serum and urine steroid profiles can reveal adrenal dysfunction and help characterize adrenal tumors and related conditions. Steroid metabolomics has therefore become an important tool for both diagnosis and research in adrenal disease.
Steroid conjugates in physiology and disease
Steroid sulfates and disulfates are increasingly recognized as physiologically relevant molecules rather than inert waste products. They can serve as circulating reservoirs and may have biological activities of their own, linking steroid biosynthetic process to broader endocrine and metabolic regulation. Studying these conjugates expands the disease relevance of the pathway beyond classic hormone measurements.
From steroid biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a steroidogenic enzyme required for hormone output? | CRISPR knockout in adrenal or gonadal cell lines |
| Does a specific patient variant alter enzyme function? | Point-mutation knock-in of the variant |
| Can a reporter track pathway activity? | Tagged knock-in of a steroidogenic gene |
| Does increased enzyme expression change steroid profiles? | Overexpression cell model |
| Which genes modify steroid pathway flux? | CRISPR library screening with steroid readouts |
| How do steroid profiles change across conditions? | Steroid metabolomics in model systems |
How to Study the steroid biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Steroid metabolomics | Panel of steroids and conjugates | Pathway-level profiling in disease and models |
| RNA sequencing | Expression of steroidogenic genes | Tissue-specific pathway analysis |
| Proteomics | Protein abundance of pathway enzymes | Validation of expression changes |
| Enzyme activity assay | Catalytic conversion of steroid substrates | Functional testing of variants |
| CRISPR knockout | Loss-of-function effects on steroid output | Causal gene testing |
| Point-mutation knock-in | Effect of specific variants | Disease variant modeling |
| Overexpression | Gain-of-function effects on steroid profiles | Pathway flux studies |
| CRISPR library screening | Genes modifying steroid pathway phenotypes | Discovery of regulators |
Steroid metabolomics
Steroid metabolomics measures panels of steroids and their conjugates in serum or urine, providing an integrated readout of steroid biosynthetic process, metabolism and excretion. This approach is particularly valuable because it captures pathway-level changes rather than single hormones.
Transcriptomics and proteomics
RNA sequencing and proteomics can quantify expression of steroidogenic enzymes and related regulators. These methods help identify tissue-specific pathway branches and candidate genes for functional follow-up.
Enzyme activity and biochemical assays
Biochemical assays can measure the catalytic activity of individual steroidogenic enzymes using substrate conversion or product formation. Such assays are essential for validating the functional impact of genetic variants and for dissecting interconversion reactions.
Genetic and CRISPR models
Knockout, point-mutation, knock-in and overexpression models allow causal testing of steroidogenic genes. These models can be combined with steroid profiling to link genotype to pathway output.
How CRISPR Can Be Used to Study GO:0006694 steroid biosynthetic process
Knockout
CRISPR knockout can remove a candidate steroidogenic gene to test whether it is required for steroid biosynthetic process. Loss-of-function models are typically combined with steroid metabolomics or targeted hormone assays to measure pathway output.
Point Mutation
Point-mutation knock-in allows researchers to introduce specific patient-associated variants into endogenous genes. This is particularly useful for disorders of steroidogenesis, where single amino acid changes can alter enzyme activity.
Knock-in
Tagged or reporter knock-in can be used to track expression and localization of steroidogenic enzymes in living cells. Such models help connect enzyme expression to pathway activity.
Overexpression
Overexpression models increase the level of a steroidogenic enzyme or regulator to test gain-of-function effects on steroid production and interconversion. These models are useful for studying pathway flux and substrate competition.
How EDITGENE Supports steroid biosynthetic process Research
Researchers studying steroid biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in steroid production, how a specific variant affects enzyme function, or which genes modify pathway output. Addressing these questions requires precise genetic models and pathway-level readouts. EDITGENE provides CRISPR-based cell model services designed to support such studies, from single-gene perturbation to library-scale screening.
Contact EDITGENE today to design your custom CRISPR model for steroid biosynthetic process research.
Frequently Asked Questions About steroid biosynthetic process
What is GO:0006694 steroid biosynthetic process?
GO:0006694 is the Gene Ontology biological process describing the chemical reactions and pathways that form steroids, compounds with a 1,2-cyclopentanoperhydrophenanthrene nucleus, including de novo formation and steroid interconversion by modification.
What genes are involved in steroid biosynthetic process?
Key genes include STAR, CYP11A1, HSD3B2, CYP21A2, CYP11B1, CYP11B2, CYP17A1, CYP19A1, SRD5A1, SRD5A2, AKR1C3, HSD17B1, HSD17B2, SULT2A1, STS, NR5A1 and POR, among others.
Where does steroid biosynthetic process occur?
It occurs in steroidogenic tissues such as the adrenal cortex, gonads and placenta, and can also occur in other tissues that express steroidogenic enzymes.
What is the difference between steroidogenesis and steroid biosynthetic process?
Steroidogenesis is a synonym for steroid biosynthetic process, and both refer to the formation and interconversion of steroids as defined by GO:0006694.
How are steroids measured in research?
Serum and urine steroid metabolomes are widely used to measure steroids and their conjugates, providing an integrated view of biosynthesis, metabolism and excretion.
What diseases are linked to defects in steroid biosynthetic process?
Defects can cause disorders of steroidogenesis such as congenital adrenal hyperplasia, and steroid biomarkers are important in adrenal disease.
What are steroid sulfates and disulfates?
They are conjugated steroids formed by sulfation, which can act as storage forms or bioactive molecules and are part of the broader steroid landscape.
How can CRISPR be used to study steroid biosynthetic process?
CRISPR knockout, point-mutation knock-in, tagged knock-in and overexpression models can test the causal role of steroidogenic genes and variants in pathway output.
What is the role of STAR in steroid biosynthesis?
STAR facilitates cholesterol transfer into mitochondria, which is a rate-limiting step for steroid hormone synthesis.
Why is steroid metabolomics useful for adrenal disease?
Steroid metabolomics captures multiple pathway products and can reveal adrenal dysfunction that single-hormone tests may miss.
Conclusion
GO:0006694 steroid biosynthetic process defines the formation and interconversion of steroids and is central to endocrine physiology, disease mechanisms and pharmacological research. Its multi-enzyme, tissue-specific nature makes integrated approaches such as steroid metabolomics, transcriptomics and CRISPR-based genetic models essential for accurate study. Understanding this pathway supports research on adrenal disease, disorders of steroidogenesis and steroid conjugate biology. For laboratories investigating steroid biosynthetic process, precise cell models and pathway-level readouts are key. EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression, library screening and bioinformatics services to help researchers connect genotype to steroid pathway function.
References
- 1. Donova MV. 2017. Steroid Bioconversions.. Methods Mol Biol 1645:1-13 PMID: 28710617
- 2. Schiffer L et al.. 2019. Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.. J Steroid Biochem Mol Biol 194:105439 PMID: 31362062
- 3. Miller WL. 2017. Steroidogenesis: Unanswered Questions.. Trends Endocrinol Metab 28(11):771-793 PMID: 29031608
- 4. Sedlaczek L. 1988. Biotransformations of steroids.. Crit Rev Biotechnol 7(3):187-236 PMID: 3064921
- 5. Lightning TA et al.. 2021. Steroid disulfates - Sulfation double trouble.. Mol Cell Endocrinol 524:111161 PMID: 33453296
- 6. Biason-Lauber A et al.. 2010. Defects of steroidogenesis.. J Endocrinol Invest 33(10):756-66 PMID: 20190554
- 7. Vítků J et al.. 2023. Steroid Conjugates and Their Physiological Role.. Physiol Res 72(S4):S317-S322 PMID: 38116768
- 8. Rege J et al.. 2019. Steroid biomarkers in human adrenal disease.. J Steroid Biochem Mol Biol 190:273-280 PMID: 30707926
